Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 12/20 | 0.86 |
| ▸ | CYP11B2 | P19099 | 11/20 | 0.86 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.86 |
| ▸ | CYP19A1 | P11511 | 8/20 | 0.75 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.75 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.75 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.71 |
| ▸ | POLB | P06746 | 1/20 | 0.71 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.71 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.71 |
| ▸ | MAPT | P10636 | 1/20 | 0.71 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.71 |
| ▸ | QPCT | Q16769 | 1/20 | 0.71 |
| ▸ | CYP4Z1 | Q86W10 | 1/20 | 0.71 |
| ▸ | QPCTL | Q9NXS2 | 1/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1024261 | 0.94 | CYP11B1 (0.84) | CYP11B1CYP11B2CYP17A1CYP19A1CYP2A6 | |
| SCHEMBL2033990 | 0.93 | CYP11B1 (1.00) | CYP11B1CYP11B2CYP17A1CYP19A1CYP2A6 | |
| Hydrochloric Acid SCHEMBL1775141 | 0.91 | CYP11B1 (0.81) | CYP11B1CYP11B2CYP17A1CYP19A1CYP2A6 | |
| SCHEMBL6488945 | 0.91 | CYP11B1 (0.90) | CYP11B1CYP11B2CYP17A1CYP19A1CYP2A6 | |
| SCHEMBL6057476 | 0.88 | CYP11B1 (0.75) | CYP11B1CYP11B2CYP17A1CYP19A1CYP2A6 | |
| SCHEMBL570342 | 0.86 | CYP11B1 (1.00) | CYP11B1CYP11B2CYP17A1CYP19A1CYP2A6 | |
| SCHEMBL2729830 | 0.85 | CYP11B1 (1.00) | CYP11B1CYP11B2CYP17A1CYP19A1CYP2A6 | |
| SCHEMBL6878562 | 0.84 | CYP11B1 (0.70) | CYP11B1CYP11B2CYP17A1CYP19A1CYP2A6 | |
| SCHEMBL77025 | 0.84 | CYP11B1 (1.00) | CYP11B1CYP11B2CYP17A1CYP19A1CYP2A6 | |
| SCHEMBL7284368 | 0.84 | CYP11B1 (0.73) | CYP11B1CYP11B2CYP17A1CYP19A1CYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8632914-B2 | Triazolium and imidazolium salts and uses thereof | UNIVERSITY HEALTH NETWORK (CA) | 2014-01-21 | — | — | US | disclosed |
| US-20130210881-A1 | ANTIMICROBIAL COMPOSITION | AGENCY FOR SCIENCE ,TECHNOLOGY AND RESEARCH (SG) | 2013-08-15 | — | — | US | disclosed |
| US-20130210881-A1 | ANTIMICROBIAL COMPOSITION | AGENCY FOR SCIENCE ,TECHNOLOGY AND RESEARCH (SG) | 2013-08-15 | — | — | US | disclosed |
| US-20110257235-A1 | TRIAZOLIUM AND IMIDAZOLIUM SALTS AND USES THEREOF | UNIVERSITY HEALTH NETWORK (CA) | 2011-10-20 | — | — | US | disclosed |
| WO-2010025558-A1 | TRIAZOLIUM AND IMIDAZOLIUM SALTS AND USES THEREOF AS ANTIMALARIALS | UNIVERSITY HAEALTH NETWORK (CA) | 2010-03-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110257235-A1 | TRIAZOLIUM AND IMIDAZOLIUM SALTS AND USES THEREOF | ARG2, ARG1, CIT | CYP11B1 1050/4885CYP11B2 1276/4885CYP17A1 4352/4885 |
| US-20130210881-A1 | ANTIMICROBIAL COMPOSITION | NOD2, MPO, NACA | CYP11B1 4802/4885CYP11B2 4790/4885CYP17A1 4831/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.